Stryker has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, as part of the newly formed company VB Spine.

VB Spine will have exclusive access to Mako Spine and Copilot for use with its implants in spine surgeries. The new company will become a strategic partner to Stryker.

This agreement also included a binding offer to acquire Stryker’s implant business in France. Sale of the company’s spinal implants business in other international markets is expected, as well. VB Spine is moving toward completing the acquisition of Stryker’s international spine businesses, pending satisfaction of legal and regulatory requirements, including all required employee consultations.

“The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,” said Kevin Lobo, chair and CEO, Stryker. “We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with VB Spine. We’re grateful to our Spine team members for their contributions and confident they’re well positioned for continued success.”

VB Spine is led by Marc, John, and Anthony Viscogliosi, co-founders of the family-owned investment office specializing in the neuro-musculoskeletal space.

“We are honored to work alongside such a talented team and are confident that, with its strong commitment to innovation, surgeon collaboration and commercial execution, VB Spine is uniquely positioned to improve patient outcomes and drive transformation in spine surgery,” said Marc, John, and Anthony Viscogliosi.